R S Choung
Overview
Explore the profile of R S Choung including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
495
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Choung R, Richard Locke 3rd G, Schleck C, Zinsmeister A, Talley N
Neurogastroenterol Motil
. 2017 Mar;
29(7).
PMID: 28256048
Background: It is unknown why functional gastrointestinal disorders (FGIDs) overlap and limited information exists on risk factors for those with overlap. Our aim was to estimate the prevalence of combinations...
2.
Choung R, Murray J, Marietta E, Van Dyke C, Ross A
Aliment Pharmacol Ther
. 2017 Jan;
45(5):643-652.
PMID: 28052442
Background: Therapy for coeliac disease (CD) mainly relies on following a gluten-free diet (GFD); however, a serum marker for gluten intake has yet to be established. Aim: To evaluate the...
3.
The incidence rate and characteristics of clinically diagnosed defecatory disorders in the community
Noelting J, Eaton J, Choung R, Zinsmeister A, Locke 3rd G, Bharucha A
Neurogastroenterol Motil
. 2016 Jun;
28(11):1690-1697.
PMID: 27254309
Background: Defecatory disorders (DD) are defined by clinical and objective features of impaired rectal evacuation. The epidemiology of DD in the population is unknown, partly because many constipated patients do...
4.
Choung R, Princen F, Stockfisch T, Torres J, Maue A, Porter C, et al.
Aliment Pharmacol Ther
. 2016 Apr;
43(12):1300-10.
PMID: 27117843
Background: Patients with Crohn's disease (CD) have serologic responses to various microbial antigens. Serologic markers are associated with aggressive forms of disease and can be detected before onset of symptoms....
5.
Marietta E, Nadeau A, Cartee A, Singh I, Rishi A, Choung R, et al.
Aliment Pharmacol Ther
. 2015 Oct;
42(11-12):1303-14.
PMID: 26423313
Background: Olmesartan-associated enteropathy (OAE) is characterised by diarrhoea, nausea, vomiting, abdominal pain, weight loss and severe sprue-like enteropathy, all of which are resolved after discontinuation of olmesartan medoximil. Aim: To...
6.
Cho S, Choung R, Saito Y, Schleck C, Zinsmeister A, Locke 3rd G, et al.
Neurogastroenterol Motil
. 2014 Nov;
27(2):212-9.
PMID: 25376877
Background: Dysphagia is considered an alarm symptom but detailed population-based data on dysphagia are lacking. We aimed to estimate in a representative USA Caucasian population, the prevalence of dysphagia and...
7.
Pleyer C, Bittner H, Locke 3rd G, Choung R, Zinsmeister A, Schleck C, et al.
Neurogastroenterol Motil
. 2014 Jun;
26(8):1163-71.
PMID: 24916517
Background: There is symptom overlap between gastro-esophageal reflux disease (GERD) and functional dyspepsia (FD). We aimed to test the hypothesis that FD cases are now more likely mislabeled as GERD....
8.
Choung R, Locke 3rd G, Schleck C, Zinsmeister A, Talley N
Aliment Pharmacol Ther
. 2013 Dec;
39(2):217-25.
PMID: 24304163
Background: The population ≥65 years is rapidly increasing, but remarkably little is known about the natural history of abdominal pain with ageing. Aim: To prospectively evaluate the natural history of...
9.
Choung R, Locke 3rd G, Francis D, Katzka D, Winkle P, Orr W, et al.
Neurogastroenterol Motil
. 2013 Sep;
26(1):13-20.
PMID: 24001105
Background: Low basal lower esophageal sphincter (LES) pressure and transient LES relaxations are major causes of gastroesophageal reflux disease (GERD). Pumosetrag, a novel selective partial 5HT3 receptor agonist, showed a...
10.
Choung R, Locke G, Schleck C, Zinsmeister A, Talley N
Neurogastroenterol Motil
. 2013 Jan;
25(5):413-9, e298.
PMID: 23360217
Background: Functional GI syndromes are known to be very prevalent, but this may be linked to unrecognized medications use. We aimed to estimate the prevalence of PPI, antidepressant, and narcotic...